Vinorelbine

What it is used for

Vinorelbine Injection is indicated:

• In combination with cisplatin for first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
• As a single agent for the treatment of patients with metastatic NSCLC

Side effects, and when to stop

The following clinically significant adverse reactions are described elsewhere in the labeling:

• Myelosuppression
• Hepatic Toxicity
• Severe Constipation and Bowel Obstruction
• Extravasation and Tissue Injury
• Neurologic Toxicity
• Pulmonary Toxicity and Respiratory Failure

Who should not take it

None

Storing it

Storage Conditions Store refrigerated between 2° and 8°C (36° and 46°F).

Do not freeze. Protect from light. Retain in carton until time of use. Discard unused portion.

Unopened vials of Vinorelbine Injection, USP are stable at 25°C (77°F) for up to 72 hours. Store diluted solutions of Vinorelbine Injection, USP at 5° to 30°C (41° to 86°F).

Vinorelbine Injection, USP is a cytotoxic drug. Follow applicable special handling and disposal procedures. 1

Sterile, Nonpyrogenic, Preservative-free. The container closure is not made with natural rubber latex.